Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma (2019)
- Authors:
- Vuolo, Francieli
- Abreu, Soraia Carvalho
- Michels, Monique
- Xisto, Débora Gonçalves
- Blanco, Natália G.
- Hallak, Jaime Eduardo Cecílio
- Zuardi, Antônio Waldo
- Crippa, José Alexandre de Souza
- Reis, Cardine Martins dos
- Bahl, Marina
- Pizzichinni, Emílio
- Maurici, Rosemeri
- Pizzichini, Márcia Margaret Menezes
- Rocco, Patricia Rieken Macedo
- Dal-Pizzol, Felipe
- USP affiliated authors: HALLAK, JAIME EDUARDO CECILIO - FMRP ; ZUARDI, ANTONIO WALDO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.ejphar.2018.11.029
- Subjects: ASMA; CANABINOIDES; FIBROSE PULMONAR
- Keywords: Asthma; Inflammation; Remodelling; Cannabidiol
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: European Journal of Pharmacology
- ISSN: 0014-2999
- Volume/Número/Paginação/Ano: v. 843, p. 251-259, 2019
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
VUOLO, Francieli et al. Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma. European Journal of Pharmacology, v. 843, p. 251-259, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2018.11.029. Acesso em: 23 jan. 2026. -
APA
Vuolo, F., Abreu, S. C., Michels, M., Xisto, D. G., Blanco, N. G., Hallak, J. E. C., et al. (2019). Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma. European Journal of Pharmacology, 843, 251-259. doi:10.1016/j.ejphar.2018.11.029 -
NLM
Vuolo F, Abreu SC, Michels M, Xisto DG, Blanco NG, Hallak JEC, Zuardi AW, Crippa JA de S, Reis CM dos, Bahl M, Pizzichinni E, Maurici R, Pizzichini MMM, Rocco PRM, Dal-Pizzol F. Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma [Internet]. European Journal of Pharmacology. 2019 ; 843 251-259.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1016/j.ejphar.2018.11.029 -
Vancouver
Vuolo F, Abreu SC, Michels M, Xisto DG, Blanco NG, Hallak JEC, Zuardi AW, Crippa JA de S, Reis CM dos, Bahl M, Pizzichinni E, Maurici R, Pizzichini MMM, Rocco PRM, Dal-Pizzol F. Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma [Internet]. European Journal of Pharmacology. 2019 ; 843 251-259.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1016/j.ejphar.2018.11.029 - Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia
- Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system
- Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion
- Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy
- Cannabidiol, a nonpsychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury
- Interaction between cannabidiol (CBD) and 'delta 9'-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids [Carta]
- Reprint of “Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)”
- Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: reversal by cannabidiol
Informações sobre o DOI: 10.1016/j.ejphar.2018.11.029 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
